Barney S. Graham
Affiliations: | Vanderbilt University, Nashville, TN |
Area:
Microbiology Biology, Cell BiologyGoogle:
"Barney Graham"Children
Sign in to add trainee| Sandra Aung | grad student | 2000 | Vanderbilt |
| Tara L. Gower | grad student | 2001 | Vanderbilt |
| Philip J. Budge | grad student | 2003 | Vanderbilt |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kanekiyo M, Gillespie RA, Midgett M, et al. (2023) Refined semi-lethal aerosol H5N1 influenza model in cynomolgus macaques for evaluation of medical countermeasures. Iscience. 26: 107830 |
| McCool RS, Musayev M, Bush SM, et al. (2023) Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope. Journal of Virology. e0092923 |
| Krug PW, Wang L, Shi W, et al. (2023) EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination. Science Advances. 9: eadg6076 |
| Bollman B, Nunna N, Bahl K, et al. (2023) An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection. Npj Vaccines. 8: 58 |
| Widge AT, Hofstetter AR, Houser KV, et al. (2023) An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults. Science Translational Medicine. 15: eade4790 |
| Peretti A, Scorpio DG, Kong WP, et al. (2023) A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques. Vaccine |
| Chang LA, Phung E, Crank MC, et al. (2022) A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine. Science Translational Medicine. 14: eade0424 |
| Milligan EC, Olstad K, Williams CA, et al. (2022) Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later. Science Translational Medicine. eadd6383 |
| Moin SM, Boyington JC, Boyoglu-Barnum S, et al. (2022) Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. Immunity |
| McMahon M, O'Dell G, Tan J, et al. (2022) Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses. Proceedings of the National Academy of Sciences of the United States of America. 119: e2206333119 |